{"resourceType":"PlanDefinition","id":"AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan","meta":{"profile":["https://www.ceosys.de/fhir/StructureDefinition/recommendation-plan"]},"text":{"status":"extensions","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: PlanDefinition</b><a name=\"AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource PlanDefinition \"AntithrombFondapProphInHospitalisedCOVID19PatientsRecommPlan\" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"file:///github/workspace/output/StructureDefinition-recommendation-plan.html\">Recommendation Plan</a></p></div><p><b>knowledgeCapability</b>: computable</p><p><b>knowledgeRepresentationLevel</b>: structured</p><p><b>url</b>: <code>https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/recommendations/intervention-plan/antithrombotic-prophylaxis-fondaparinux</code></p><p><b>version</b>: 0.1</p><p><b>name</b>: AntithromboticProphylaxisWithFondaparinux</p><p><b>title</b>: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</p><p><b>type</b>: ECA Rule <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://build.fhir.org/codesystem-plan-definition-type.html\">PlanDefinitionType</a>#eca-rule)</span></p><p><b>status</b>: active</p><p><b>experimental</b>: true</p><p><b>subject</b>: <a href=\"EvidenceVariable-PopHospitalisedCOVID19PatientsWOVenousThrombosisWITHCI.html\">COVID19_patients_without_venous_thrombosis_with_contraindications</a></p><p><b>date</b>: 2022-04-27</p><p><b>publisher</b>: NUM CODEX+ CELIDA</p><p><b>description</b>: Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients</p><h3>Actions</h3><table class=\"grid\"><tr><td>-</td><td><b>Code</b></td><td><b>SelectionBehavior</b></td><td><b>Definition[x]</b></td></tr><tr><td>*</td><td>Administration of substance (procedure) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#432102000)</span></td><td>exactly-one</td><td><a href=\"ActivityDefinition-AntithromboticProphylaxisFondaparinuxSubcutaneous.html\">ProphylacticFondaparinuxApplicationActivity</a></td></tr></table></div>"},"extension":[{"url":"http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeCapability","valueCode":"computable"},{"url":"http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-knowledgeRepresentationLevel","valueCode":"structured"}],"url":"https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/recommendations/intervention-plan/antithrombotic-prophylaxis-fondaparinux","version":"0.1","name":"AntithromboticProphylaxisWithFondaparinux","title":"Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients","type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/plan-definition-type","code":"eca-rule"}]},"status":"active","experimental":true,"subjectCanonical":"https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/recommendations/population/hospitalised-covid19-patients-no-venous-thrombosis-with-LMWH-contraindications","date":"2022-04-27","publisher":"NUM CODEX+ CELIDA","description":"Antithrombotic prophylaxis with Fondaparinux in hospitalised COVID-19 patients","action":[{"code":{"coding":[{"system":"http://snomed.info/sct","code":"432102000","display":"Administration of substance (procedure)"}]},"selectionBehavior":"exactly-one","definitionCanonical":"https://www.netzwerk-universitaetsmedizin.de/fhir/codex-celida/recommendations/recommended-action/drug-administration-action/antithrombotic-prophylaxis-fondaparinux-administration"}]}